Colchicine in Vascular Inflammation Assessed With PET Imaging

Summary

The purpose of this trial is to assess the effects of colchicine on vascular inflammation measured by (FDG)-PET imaging in patients with atherosclerotic vascular disease. This effect will also be measured by soluble plasma biomarkers. Finally, an optional pharmacogenomic investigation will be performed to identify genetic biomarkers of patient response.

Timeline

Start

2014-05

Primary completion

2015-07

Completion

2016-01

Drugs

Indications